J1190 HCPCS code: Injection, dexrazoxane hydrochloride, per 250 mg
J1190 is the HCPCS Level II code for injection, dexrazoxane hydrochloride, per 250 mg. In 2024 Medicare paid an average of $74.45 per service for J1190 across 1,364 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 8 per day on outpatient hospital claims. Medicare volume fell 23% from 2022 to 2024 (1,783 to 1,364 services). In 2024, about 158 clinicians billed Medicare for J1190 for 99 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1997-01-01 |
| Last action effective | 1997-01-01 |
Who bills J1190 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 158 |
| Medicare beneficiaries | 99 |
| States with claims | 2 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1190, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,783 | 118 | $172.56 | $137.77 |
| 2023 | 1,346 | 98 | $127.50 | $101.52 |
| 2024 | 1,364 | 99 | $93.53 | $74.45 |
States with the most J1190 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 316 | $69.85 |
| Florida | 141 | $73.25 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 8 | Prescribing Information |
| practitioner claims | 8 | Prescribing Information |
What changed for J1190
- 1997-01-01: J1190 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1190?
J1190 is the HCPCS Level II code for injection, dexrazoxane hydrochloride, per 250 mg. Short descriptor: "Dexrazoxane hcl injection".
How much does Medicare pay for J1190?
In 2024, the average Medicare payment was $74.45 per service (average allowed $93.53).
Does Medicare cover J1190?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J1190 can be billed per day?
8 on outpatient hospital claims; 8 on practitioner claims (NCCI medically unlikely edits).
Related J11 codes
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg
- J1105 — Dexmedetomidine, oral, 1 mcg
- J1110 — Injection, dihydroergotamine mesylate, per 1 mg
- J1120 — Injection, acetazolamide sodium, up to 500 mg
- J1130 — Injection, diclofenac sodium, 0.5 mg
- J1160 — Injection, digoxin, up to 0.5 mg
- J1162 — Injection, digoxin immune fab (ovine), per vial
- J1163 — Injection, diltiazem hydrochloride, 0.5 mg
- J1164 — Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165 — Injection, phenytoin sodium, per 50 mg
- J1170 — Injection, hydromorphone, up to 4 mg
- J1171 — Injection, hydromorphone, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1190
- Watch J1190 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1190
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.